Publication:
Impact of infectious diseases consultation on the management of Staphylococcus aureus bacteraemia in children

dc.contributor.authorRebecca B. Saundersonen_US
dc.contributor.authorTheodore Gouliourisen_US
dc.contributor.authorEdward J. Cartwrighten_US
dc.contributor.authorEmma J. Nickersonen_US
dc.contributor.authorSani H. Aliyuen_US
dc.contributor.authorD. Roddy O'Donnellen_US
dc.contributor.authorWilf Kelsallen_US
dc.contributor.authorD. Limmathurotsakulen_US
dc.contributor.authorSharon J. Peacocken_US
dc.contributor.authorM. Estée Töröken_US
dc.contributor.otherUniversity of Cambridgeen_US
dc.contributor.otherCambridge University Hospitals NHS Foundation Trusten_US
dc.contributor.otherPublic Health Englanden_US
dc.contributor.otherMahidol Universityen_US
dc.contributor.otherWellcome Trust Sanger Instituteen_US
dc.date.accessioned2018-11-09T03:00:20Z
dc.date.available2018-11-09T03:00:20Z
dc.date.issued2014-01-01en_US
dc.description.abstractObjectives: Infectious diseases consultation (IDC) in adults with Staphylococcus aureus bacteraemia (SAB) has been shown to improve management and outcome. The aim of this study was to evaluate the impact of IDC on the management of SAB in children. Study design: Observational cohort study of children with SAB. Setting: Cambridge University Hospitals National Health Service (NHS) Foundation Trust, a large acute NHS Trust in the UK. Participants: All children with SAB admitted to the Cambridge University Hospitals NHS Foundation Trust between 16 July 2006 and 31 December 2012. Methods: Children with SAB between 2006 and 31 October 2009 were managed by routine clinical care (pre-IDC group) and data were collected retrospectively by case notes review. An IDC service for SAB was introduced in November 2009. All children with SAB were reviewed regularly and data were collected prospectively (IDC group) until 31 December 2012. Baseline characteristics, quality metrics and outcome were compared between the pre-IDC group and IDC group. Results: There were 66 episodes of SAB in 63 children - 28 patients (30 episodes) in the pre-IDC group, and 35 patients (36 episodes) in the IDC group. The median age was 3.4 years (IQR 0.2-10.7 years). Patients in the IDC group were more likely to have echocardiography performed, a removable focus of infection identified and to receive a longer course of intravenous antimicrobial therapy. There were no differences in total duration of antibiotic therapy, duration of hospital admission or outcome at 30 or 90 days following onset of SAB. Conclusions: IDC resulted in improvements in the investigation and management of SAB in children.en_US
dc.identifier.citationBMJ Open. Vol.4, No.7 (2014)en_US
dc.identifier.doi10.1136/bmjopen-2013-004659en_US
dc.identifier.issn20446055en_US
dc.identifier.other2-s2.0-84903648831en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/34747
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84903648831&origin=inwarden_US
dc.subjectMedicineen_US
dc.titleImpact of infectious diseases consultation on the management of Staphylococcus aureus bacteraemia in childrenen_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84903648831&origin=inwarden_US

Files

Collections